Related Experiment Video
Updated: Mar 23, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Functional dyspepsia: new insights into pathogenesis and therapy
1Department of Gastroenterology, John Hunter Hospital, The University of Newcastle Australia Faculty of Health and Medicine, Newcastle, Australia.
Functional dyspepsia (FD) affects 10% of people, causing chronic upper abdominal discomfort. Emerging evidence links FD to gastroesophageal reflux disease and suggests infections or food may trigger symptoms in some patients.
Area of Science:
- Gastroenterology and Internal Medicine
- Clinical Therapeutics and Diagnostics
Background:
- Functional dyspepsia (FD) is a prevalent condition affecting 10% of the population, characterized by chronic upper abdominal symptoms.
- FD encompasses Postprandial Distress Syndrome (PDS) and Epigastric Pain Syndrome (EPS), increasingly recognized as distinct clinical entities.
- Growing evidence suggests a potential overlap between FD and gastroesophageal reflux disease (GERD) in a significant patient subset.
Purpose of the Study:
- To review current understanding of functional dyspepsia (FD) pathophysiology, diagnosis, and management strategies.
- To highlight emerging insights into potential causes of FD, including infections and dietary factors.
- To discuss therapeutic approaches for different FD subtypes, including acid suppression, prokinetics, and pharmacologic interventions.
Main Methods:
- Review of clinical history for diagnosis, with exclusion of peptic ulcer and malignancy via endoscopy.
- Analysis of accumulating data on the pathophysiology and potential triggers of FD.
- Evaluation of treatment outcomes for various therapeutic options in FD management.
Main Results:
- Duodenal eosinophilia and Helicobacter pylori infection are recognized pathologies associated with FD, though H. pylori eradication benefits only a minority.
- Acid suppression therapy is a first-line treatment for EPS, with H2 blockers considered even if proton pump inhibitors fail.
- Prokinetics are preferred for PDS, while low-dose tricyclic antidepressants or mirtazapine are second-line options, excluding SSRIs.
Conclusions:
- FD is a complex syndrome with multifactorial origins, requiring tailored treatment approaches based on symptom presentation.
- Further research is needed to fully elucidate the causes of FD and optimize therapeutic strategies.
- Understanding the spectrum of FD, including its relationship with GERD and potential underlying pathologies, is crucial for effective patient care.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

